Workflow
德琪医药-B(06996.HK)拟8月22日举行董事会会议批准中期业绩

Group 1 - The company, 德琪医药-B (06996.HK), announced that it will hold a board meeting on August 22, 2025, to consider and approve its interim results for the six months ending June 30, 2025 [1]